THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
Herbert L. DUPONT,Zhi-Dong JIANG
申请号:
US16481187
公开号:
US20200147151A1
申请日:
2018.01.30
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present disclosure provides human fecal microbiota compositions, including fresh, frozen, and lyophilized compositions, for the treatment of disorders associated with dysfunctional microbiota, such as recurrent Clostridium difficile infection. In particular, the fecal microbiota composition comprises a cryoprotectant sugar, such as mannitol.